³Ô¹ÏÍøÕ¾

Latest biotechnology News | Page 10

Microba completes stage one screening for its autoimmune disease program
³Ô¹ÏÍøÕ¾ Reconstruction Fund (NRF) investment mandate released
Clairvoyant Surpasses 50 Per Cent Randomization in its Phase 2b Psilocybin Therapy Trial for Alcohol Use Disorder
University of Manchester, Boots and No7 beauty company secure multi-million-pound funding for inclusive dermatology research programme
Researchers advance ‘placenta-on-a-chip’ with sensing, imaging technology
Federal government backs the development of treatment for childhood brain cancer
Dimerix’s ACTION3 investigational new drug approved in China
Medical science a ‘priority area’ for new Industry Growth Program
AusBiotech weighs in on Australia’s RNA future
Oral delivery possibility for silica-based C’Dots
Broad Bean Thrives Despite Hyperactive Ion Channel
Drug resistance may make common infections like thrush untreatable
The Cell and Gene Catalyst call for change in submission to scope of practice review
Alterity Therapeutics raises $4.8 million in new placement
Orthocell announces final positive results of cell therapy in ‘tennis elbow’ study
Anteris reports positive 30-Day haemodynamic results from trial
Victoria’s Consular Corps visit Monash, scientists showcase latest innovations
UQ leads state at Life Sciences Queensland Awards
Biotech headed to Hill for AusBiotech’s Policy Forum
Alterity Therapeutics announces presentation of new data for ATH434
US FDA grants Argenica Therapeutics’ ARG-007 orphan drug designation
Neuren Pharmaceuticals completes Phelan-McDermid syndrome Phase 2 trial 
University of Queensland to establish world-leading mRNA laboratory
Telix says first patient dosed in ProstACT study of prostate cancer candidate
New report demonstrates benefit of long-term policy commitment
ARC Discovery project funding for geometry of the genome and the engineering of solid-state sodium batteries announced
HaemaLogiX Announces Appointment of Damian Clarke-Bruce as Managing Director and CEO
New order for brewer’s yeast
Clarity says recruitment target achieved for Phase II SAR-Bombesin prostate cancer trial
Immutep announces the completion of key stage of AIPAC-003 trial in metastatic breast cancer
Cornell honored for work with international scholars
Scientists one step closer to re-writing world’s first synthetic yeast genome, unravelling the fundamental building blocks of life
November is Pancreatic Cancer Awareness Month
Appointment of Biological Sciences and Biotechnology specialist
Alum offers advice for trans allyship
UNSW tops ARC grants for Infrastructure, Equipment and Facilities
Imugene says next cohort reached in intravenous arms of monotherapy and combination study
New report quantifies the importance of R&D Tax Incentive on Australian economy
AusBiotech 2023 underway in Queensland
AusBiotech Board election result announced
AstraZeneca announces collaboration and investment agreement with Cellectis to accelerate cell therapy and genomic medicine ambitions
Bioprospecting the unknown: how bacterial enzymes encoded by unknown genes might help clean up pollution
New report quantifies impact of R&D Tax Incentive in Australia’s life sciences sector
It’s in our DNA: Australia’s biggest week in life sciences to advance biotech
Opthea announces leadership transition with the appointment of US-based executives
Emyria secures ethics endorsement for MDMA authorised prescriber application
AusBioInvest 2023 connects innovators with investment
Monash maintains position as a global frontrunner across university rankings